This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masui, H. Articles by Gill, G. N. Search for Related Content PubMed PubMed Citation Articles by Masui, H. Articles by Gill, G. N.

Enhanced Tumorigenesis of NR6 Cells Which Express Non-Down-Regulating Epidermal Growth Factor Receptors¹

Memorial Sloan Kettering Institute, New York, New York 10021 [H. M.]; and Departments of Medicine [C. S. L., M. G. R., G. N. G.] and Pathology [A. W.] and The Howard Hughes Medical Institute [M. G. R.], University of California-San Diego, La Jolla, California 92093-0650

Sequences in the regulatory carboxyl terminus of the epidermal growth factor (EGF) receptor are required for ligand-induced internalization via a high-affinity saturable endocytic pathway and for receptor down-regulation. To investigate the role of down-regulation in attenuating mitogenic signals, we compared the ability of NR6 cells expressing holo and mutant down-regulation defective EGF receptors to form tumors in athymic mice. NR6 cells expressing mutant EGF receptors reproducibly formed rapidly growing tumors, whereas cells expressing holo EGF receptors had a low tumorigenic potential. Serial passage of tumors of NR6 cells expressing mutant EGF receptors resulted in an enhanced rate of tumor formation that directly correlated with increased expression of mutant receptors. Tumor growth was inhibited by a competitive antagonist anti-EGF receptor monoclonal antibody. Excessive signaling from the cell surface can result from lack of sequences required for endocytosis and from saturation of endocytic mechanisms. Non-down-regulating kinase-active EGF receptors provide an especially strong growth signal, manifested as rapid tumor growth in athymic mice.

¹ These studies were supported by grants from the American Cancer Society, The Council for Tobacco Research, Inc. (G. N. G.), and the NIH (CA42060 and CA37641)(H. M.).

² M. G. R. is an investigator of the Howard Hughes Medical Institute.

³ To whom requests for reprints should be addressed.

Received 7/ 8/91. Accepted 9/ 5/91.

This article has been cited by other articles:

				M. A. Barbieri, C. M. Heath, E. M. Peters, A. Wells, J. N. Davis, and P. D. Stahl Phosphatidylinositol-4-phosphate 5-Kinase-1beta Is Essential for Epidermal Growth Factor Receptor-mediated Endocytosis J. Biol. Chem., December 7, 2001; 276(50): 47212 - 47216. [Abstract] [Full Text] [PDF]

				R. De Wit, C. M.J. Hendrix, J. Boonstra, A. J. Verkleij, and J. A. Post Large-Scale Screening Assay to Measure Epidermal Growth Factor Internalization J Biomol Screen, June 1, 2000; 5(3): 133 - 139. [Abstract] [PDF]

				L. Frederick, X.-Y. Wang, G. Eley, and C. D. James Diversity and Frequency of Epidermal Growth Factor Receptor Mutations in Human Glioblastomas Cancer Res., March 1, 2000; 60(5): 1383 - 1387. [Abstract] [Full Text]

				J. M. Haugh, A. C. Huang, H. S. Wiley, A. Wells, and D. A. Lauffenburger Internalized Epidermal Growth Factor Receptors Participate in the Activation of p21ras in Fibroblasts J. Biol. Chem., November 26, 1999; 274(48): 34350 - 34360. [Abstract] [Full Text] [PDF]

				C. Mineo, G. N. Gill, and R. G. W. Anderson Regulated Migration of Epidermal Growth Factor Receptor from Caveolae J. Biol. Chem., October 22, 1999; 274(43): 30636 - 30643. [Abstract] [Full Text] [PDF]

				M. Vecchi and G. Carpenter Constitutive Proteolysis of the ErbB-4 Receptor Tyrosine Kinase by a Unique, Sequential Mechanism J. Cell Biol., November 17, 1997; 139(4): 995 - 1003. [Abstract] [Full Text] [PDF]

				J. Dietrich, J. Kastrup, B. L. Nielsen, N. Odum, and C. Geisler Regulation and Function of the CD3{gamma} DxxxLL Motif: A Binding Site for Adaptor Protein-1 and Adaptor Protein-2 in Vitro J. Cell Biol., July 28, 1997; 138(2): 271 - 281. [Abstract] [Full Text] [PDF]

				S. v. Delft, C. Schumacher, W. Hage, A. J. Verkleij, and P. M.P. v. B. e. Henegouwen Association and Colocalization of Eps15 with Adaptor Protein-2 and Clathrin J. Cell Biol., February 24, 1997; 136(4): 811 - 821. [Abstract] [Full Text] [PDF]

				H.-J. S. Huang, M. Nagane, C. K. Klingbeil, H. Lin, R. Nishikawa, X.-D. Ji, C.-M. Huang, G. N. Gill, H. S. Wiley, and W. K. Cavenee The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling J. Biol. Chem., January 31, 1997; 272(5): 2927 - 2935. [Abstract] [Full Text] [PDF]

				T. Sasaoka, W. J. Langlois, F. Bai, D. W. Rose, J. W. Leitner, S. J. Decker, A. R. Saltiel, G. N. Gill, M. Kobayashi, B. Draznin, et al. Involvement of ErbB2 in the Signaling Pathway Leading to Cell Cycle Progression from a Truncated Epidermal Growth Factor Receptor Lacking the C-terminal Autophosphorylation Sites J. Biol. Chem., April 5, 1996; 271(14): 8338 - 8344. [Abstract] [Full Text] [PDF]

				M. A. Sturtevant, J. W. O'Neill, and E. Bier Down-regulation of Drosophila Egf-r mRNA levels following hyperactivated receptor signaling Development, September 1, 1994; 120(9): 2593 - 2600. [Abstract] [PDF]